NeuroPace, Inc.
NPCE · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $79,906 | $65,421 | $45,520 | $45,183 |
| % Growth | 22.1% | 43.7% | 0.7% | – |
| Cost of Goods Sold | $20,821 | $17,299 | $13,027 | $11,748 |
| Gross Profit | $59,085 | $48,122 | $32,493 | $33,435 |
| % Margin | 73.9% | 73.6% | 71.4% | 74% |
| R&D Expenses | $23,653 | $20,778 | $21,946 | $18,211 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $57,103 | $54,518 | $51,341 | $38,961 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $80,756 | $75,296 | $73,287 | $57,172 |
| Operating Income | -$21,671 | -$27,174 | -$40,794 | -$23,737 |
| % Margin | -27.1% | -41.5% | -89.6% | -52.5% |
| Other Income/Exp. Net | -$5,470 | -$5,782 | -$6,288 | -$12,343 |
| Pre-Tax Income | -$27,141 | -$32,956 | -$47,082 | -$36,080 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$27,141 | -$32,956 | -$47,082 | -$36,080 |
| % Margin | -34% | -50.4% | -103.4% | -79.9% |
| EPS | -0.93 | -1.27 | -1.91 | -2.17 |
| % Growth | 26.8% | 33.5% | 12% | – |
| EPS Diluted | -0.93 | -1.27 | -1.91 | -2.17 |
| Weighted Avg Shares Out | 29,126 | 25,852 | 24,595 | 16,609 |
| Weighted Avg Shares Out Dil | 29,126 | 25,852 | 24,595 | 16,609 |
| Supplemental Information | – | – | – | – |
| Interest Income | $3,024 | $3,050 | $1,578 | $448 |
| Interest Expense | $8,798 | $8,517 | $7,529 | $7,410 |
| Depreciation & Amortization | $1,769 | $1,605 | $2,987 | $296 |
| EBITDA | -$16,574 | -$22,834 | -$36,566 | -$28,374 |
| % Margin | -20.7% | -34.9% | -80.3% | -62.8% |